Effect of triclosan on the pathogenesis of allergic diseases among children

J Expo Sci Environ Epidemiol. 2022 Jan;32(1):60-68. doi: 10.1038/s41370-021-00304-w. Epub 2021 Mar 2.

Abstract

Background: Few studies have assessed associations between allergic diseases and antibacterial agents in Taiwanese children.

Objective: This study aimed to investigate the association of triclosan (TCS) exposure with allergic diseases among preschoolers, disease-specific IgE titers, and a child's sex.

Methods: Pediatric data were obtained from the Childhood Environment and Allergic Diseases Study (CEAS; 2010) cohort, and their urine and blood samples were used to analyze TCS and IgE concentrations (age 3 group). Three years later, clinical data were obtained again from the age 3 group (age 6 group). Correlations of TCS levels at ages 3 and 6 years with IgE levels and allergic diseases were evaluated.

Results: The TCS levels were higher at age 3 than at age 6 (geometric mean, 1.05 ng/ml vs 0.37 ng/ml). TCS levels were positively correlated with serum IgE levels at ages 3 and 6 years. Asthma and atopic dermatitis were significantly associated with TCS (adjusted OR 1.14, 95% confidence interval [CI] 1.01-1.29; OR 1.22, 95% CI 1.05-1.41). Sex-stratified analysis revealed that TCS levels were positively correlated with IgE levels among boys in the age 6 group and significantly associated with asthma, allergic rhinitis, and atopic dermatitis among boys.

Significance: TCS exposure is associated with IgE levels and a potentially high risk of pediatric atopic disorders.

Keywords: Allergic diseases; IgE levels; Triclosan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma*
  • Child
  • Child, Preschool
  • Dermatitis, Atopic* / chemically induced
  • Humans
  • Hypersensitivity*
  • Immunoglobulin E
  • Male
  • Triclosan* / adverse effects

Substances

  • Immunoglobulin E
  • Triclosan